Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
337. lappuse
... plate 50 Microbiological assay , turbidimetric 29 Microorganism count Nonaqueous titrations ( and compleximetric ) 22 Paper chromatographic identity 43 Penicillenate and penamaidate content 30 Penicillin chemical assay Penicillin ...
... plate 50 Microbiological assay , turbidimetric 29 Microorganism count Nonaqueous titrations ( and compleximetric ) 22 Paper chromatographic identity 43 Penicillenate and penamaidate content 30 Penicillin chemical assay Penicillin ...
354. lappuse
... plates with sterile por- celain tops , glazed on the outside . Allow plates to stand at room tempera- ture for 48 hours prior to use as a con- trol on the sterility of the plates . ( 8 ) Medium H. Prepare , sterilize , and dispense as ...
... plates with sterile por- celain tops , glazed on the outside . Allow plates to stand at room tempera- ture for 48 hours prior to use as a con- trol on the sterility of the plates . ( 8 ) Medium H. Prepare , sterilize , and dispense as ...
364. lappuse
... plates or test broth . Store the test organism suspension under refrigeration . ( 2 ) Method 2. Proceed as directed in paragraph ( b ) ( 1 ) of this section , except in lieu of paragraph ( b ) ( 1 ) ( ii ) thereof , heat - shock and ...
... plates or test broth . Store the test organism suspension under refrigeration . ( 2 ) Method 2. Proceed as directed in paragraph ( b ) ( 1 ) of this section , except in lieu of paragraph ( b ) ( 1 ) ( ii ) thereof , heat - shock and ...
365. lappuse
... plates to assure the viabil- ity of the spores and to determine the amount of spore suspension to be added to each 100 milliliters of agar . Main- tain the spore suspension under refrig- eration . ( 4 ) [ Reserved ] ( 5 ) Method 5 ...
... plates to assure the viabil- ity of the spores and to determine the amount of spore suspension to be added to each 100 milliliters of agar . Main- tain the spore suspension under refrig- eration . ( 4 ) [ Reserved ] ( 5 ) Method 5 ...
366. lappuse
... plates ( three plates for each response line solution , except the reference con- centration solution , which is included on each plate ) . On each set of three plates , fill three alternate cylinders with the reference concentration ...
... plates ( three plates for each response line solution , except the reference con- centration solution , which is included on each plate ) . On each set of three plates , fill three alternate cylinders with the reference concentration ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning